Physician profile
Norman Weinstein
NPI 1992754360
$6,167.19
in general payments reported to CMS, 2019-2025
25 companies · $35.10 in 2025
The $35.10 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,246 · 2020: $1,060 · 2021: $975 · 2022: $343 · 2023: $199 · 2024: $309 · 2025: $35.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $543.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $542.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $2,998.12 | 2019-2020 | |
| Boston Scientific Corporation | $1,269.20 | 2019-2022 | |
| Medtronic, INC. | $247.18 | 2021-2024 | Hawkone, Chocolate Pta Balloon Catheter |
| Janssen Pharmaceuticals, INC | $213.79 | 2019-2020 | |
| Shockwave Medical, INC | $157.01 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novartis Pharmaceuticals Corporation | $156.36 | 2020-2023 | |
| Cardiovascular Systems INC. | $140.05 | 2019-2022 | |
| Nuwellis, INC. | $118.96 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $113.67 | 2019-2024 | Lifevest |
| Pfizer INC. | $95.64 | 2019-2023 | |
| Abiomed | $92.07 | 2021-2024 | Impella |
| Amgen INC. | $81.80 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $78.27 | 2021-2023 | Jardiance |
| Astrazeneca Pharmaceuticals Lp | $76.54 | 2019-2021 | |
| Abbott Laboratories | $63.90 | 2021-2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $51.57 | 2022-2024 | Zilver Ptx |
| Angiodynamics, INC. | $51.05 | 2022 | |
| Intact Vascular, INC. | $34.47 | 2019 | |
| Elutia, INC. | $33.04 | 2019-2020 | |
| Lexicon Pharmaceuticals, INC. | $21.82 | 2023 | Inpefa |
| Baxter Healthcare | $19.63 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Terumo Medical Corporation | $14.36 | 2024 | Navicross |
| Actelion Pharmaceuticals US, INC. | $13.81 | 2019 | |
| Braemar Manufacturing, LLC | $13.63 | 2019 | |
| Endologix LLC | $11.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Norman Weinstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.